Werbung
Werbung

AVNS

AVNS logo

Avanos Medical, Inc.

12.35
USD
Gesponsert
+0.09
+0.75%
09. Jan., 15:59 UTC -5
Geschlossen
exchange

Nach-Markt

12.31

-0.04
-0.34%

AVNS Ergebnisberichte

Positives Überraschungsverhältnis

AVNS übertreffen die 29 der letzten 40Schätzungen.

73%

Nächster Bericht

Datum des nächsten Berichts
24. Feb. 2026
Estimate for Q4 25 (Revenue/ EPS)
$178.19M
/
$0.25
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+0.22%
/
+13.64%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
-0.78%
/
-40.48%

Avanos Medical, Inc. earnings per share and revenue

On 05. Nov. 2025, AVNS reported earnings of 0.22 USD per share (EPS) for Q3 25, beating the estimate of 0.12 USD, resulting in a 79.74% surprise. Revenue reached 177.80 million, compared to an expected 167.79 million, with a 5.97% difference. The market reacted with a -5.66% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of 0.25 USD, with revenue projected to reach 178.19 million USD, implying an increase of 13.64% EPS, and increase of 0.22% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
AngioDynamics, Inc.
Report Date
06. Jan. 2026 For Q2 26
Estimate
-$0.10
Aktuell
$0.00
Überraschung
+100.00%
FAQ
For Q3 2025, Avanos Medical, Inc. reported EPS of $0.22, beating estimates by 79.74%, and revenue of $177.80M, 5.97% above expectations.
The stock price moved down -5.66%, changed from $11.30 before the earnings release to $10.66 the day after.
The next earning report is scheduled for 24. Feb. 2026.
Based on 3 analysts, Avanos Medical, Inc. is expected to report EPS of $0.25 and revenue of $178.19M for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung